San Mateo, Calif. -- Despite a down day on Wall Street, shares of San Mateo-based BioForm Medical rose nearly 7% in their trading debut on Wednesday after the developer of products used by plastic surgeons priced its initial public offering. The company expects to raise $80 million after pricing 10 million shares at $8 each, below its projected range of $9-$11. Shares of the company, trading under the symbol "BFRM" on the Nasdaq National Market, closed at $8.55. Its core product, Radiesse, is an injectable dermal filler designed to provide aesthetic improvement for patients.
http://biz.yahoo.com/prnews/071107/aqw093.html?.v=26
http://www.bioformmedical.com
Sponsors
Listings
Notices
Recent Posts
- Thoma Bravo Completes $1.3 Billion Deal for Blue Coat Systems
- Milpitas-Based SanDisk Acquires Sunnyvale-Based FlashSoft
- Santa Clara-Based Vantage Data Centers Lands $135 Million Credit Facility
- Parthenon Capital Partners Raises $700 Million for New Fund
- Cisco Report: Mobile Data Traffic to Increase 18-Fold by 2016
- Newark-Based LUMEnergi Names Barry Weinbaum as President and CEO
- Campbell-Based AlienVault Raises Additional $2 Million
- San Jose-Based Solar Junction Raises $19.2 Million in Fourth Round
- European Commission Approves Google's $12.5 Billion Deal for Motorola
- Santa Clara-Based Hitachi Data Systems Completes Deal for Shoden
Editor: Rich Scherr
For news tips and editorial issues,
contact editor Rich Scherr at
rich@techwiremedia.com
For advertising information, contract
Parul Nath at parul@techwiremedia.com
A Service of Tech Wire Media
Archives
- February 12, 2012 - February 18, 2012
- February 5, 2012 - February 11, 2012
- January 29, 2012 - February 4, 2012
- January 22, 2012 - January 28, 2012
- January 15, 2012 - January 21, 2012
- January 8, 2012 - January 14, 2012
- January 1, 2012 - January 7, 2012
- December 18, 2011 - December 24, 2011
- December 11, 2011 - December 17, 2011
- December 4, 2011 - December 10, 2011
